An Evidence-based Protocol for Smoking Cessation for Persons with Psychotic Disorders

REFERENCES

• Baker, A., Richmond, R., Haile, M., Lewin, T.J., Hons, B., Vaughan, J.C. (2006). A randomized controlled trial of smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 1934–1942.
   PubMed Web of Science ®Google Scholar
• Chou, K.R., Chen, R., Lee, J.F., Ku, C.H., & Lu, R.B. (2004). The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies, 41, 321–330.
   PubMed Web of Science ®Google Scholar
• Cleveland Clinic Center. (2005). Diabetes and smoking: Another reason to quit. Retrieved April 8, 2008 from http://www.clevelandclinic.org/health/heatlh-info
   Google Scholar
• de Leon, J. & Diaz, F. (2005). A meta-anaylsis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135–157.
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. (2007). Adult Cigarette Smoking in the United States: Current Estimates. Retrieved October 28, 2007, from http://www.cdc.gov/tobacco/data_statistics/Factsheets/adult_cig_smoking.htm
   Google Scholar
• DiClemente, C.C., Prochaska, J.O., Fairhurst, S.K., Velicer, W.F., Valasquez, M.M., & Rossi, J.S. (1991) The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology, 59(2), 295–304.
   PubMed Web of Science ®Google Scholar
• El-Guebaly, N., Cathart, J., Currie, S., Brown, D., & Gloster, S. (2002). Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatric Services, 53, 1166–1170.
   PubMed Web of Science ®Google Scholar
• Evins, A.E., Cather, C., Culhane, M.A., Birnbaum, A., Horowitz, J., Hsieh, E. (2007). A 12 week double-blind, placebo-controlled study of buproprion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmocology, 27(4), 380–386.
   PubMed Web of Science ®Google Scholar
• Evins, A.E., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M.A., Olm-Shipman, C.M. (2005). A double-blind, placebo-controlled trial of buproprion for smoking cessation in schizophrenia. Journal of Clinical Psychopharmocology, 25(3), 218–225.
   PubMed Web of Science ®Google Scholar
• Fiore, M.C., Baily, W.C., Cohen, S.J., Dorfman, S.F., Goldstein, M.G., Gritz, E.R. (2000). Treating tobacco use and dependence. Clinical practice guidelines. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.
   Google Scholar
• Gallagher, S.M., Penn, P.E., Schindler, E., & Layne, W. (2007). A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs, 39(4), 487–497.
   PubMed Web of Science ®Google Scholar
• George, T., Vessicchio, J.C., Termine, A., Bregartner, T.A., Feingold, A., Rounsaville, B.J. (2002). A placebo controlled trial of buproprion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53–61.
   PubMed Web of Science ®Google Scholar
• George, T., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.
   PubMed Web of Science ®Google Scholar
• Hughes, J. (1993). Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. Journal of Clinical Psychiatry, 54, 109–114.
   PubMed Web of Science ®Google Scholar
• Jaen, C., Stange, K., Tumiel, L., & Nutting, P. (1997). Missed opportunities for prevention: Smoking cessation advice and the competing demands of practice. Journal of Family Practic, 45(4), 348–354.
   PubMedGoogle Scholar
• Lasser, K., Wesley, B.J, Wollhandler, S, Himmelstein, D.U., McCormick, D., & Bor, D.H. (2000). Smoking and mental illness: A population-based prevalence study. The Journal of the American Medical Association, 284(20), 2606–2610.
   PubMed Web of Science ®Google Scholar
• Macleod, Z.R., Charles, M.A., Arnaldi, V.C., & Adams, I.M. (2003). Telephone counseling as an adjunct to nicotine patches in smoking cessation: A randomized controlled trial. Medical Journal of Australia, 179,349–352.
   PubMed Web of Science ®Google Scholar
• New York City Department of Health and Mental Hygiene (2008). What is mental illness? Retrieved August 8, 2008, from http://www.nyc.gov
   Google Scholar
• Nides, M., Oncken, C., Gonzales, D., Rennard, S., Watsky, E.J., Anziano, R. et al. (2006) Smoking cessation with varenicline, a selective alpha 4 beta 2 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo and buproprion-controlled trial with 1-year follow-up. Archives of Internal Medicine, 166, 1561–1568.
   PubMed Web of Science ®Google Scholar
• Prochaska, J.J., & Goldstein, M. (1991). Process of smoking cessation: Implications for clinicians. Clinics in Chest Medicine, 12, 727–735.
   PubMed Web of Science ®Google Scholar
• Prochaska, J.J., Leek, D.M., Hall, S.E., & Hall, S.M. (2007). Cognitive interviews for measurement evaluation of the Fagerström Test for Nicotine Dependence (FTND) in smokers with schizophrenia spectrum disorders. Addictive Behaviors 32, 793–802.
   PubMedGoogle Scholar
• Ranney, L., Melvin, C., Lux, L., McClain, E., & Lohr, K.N. (2006). Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Annals of Internal Medicine, 145,845–856.
   PubMed Web of Science ®Google Scholar
• Stapleton, J.A., Watson, L., Spirling, L.I., Smith, R., Milbrandt, A., Ratcliffe, M. et al. (2007). Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction, 103, 146–154.
   PubMed Web of Science ®Google Scholar
• Steinberg, M.L., Ziedonis, D.M., Krejci, J.A., & Brandon, T.H. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psycology, 72, 723– 728.
   PubMed Web of Science ®Google Scholar
• Stetler, C. B., (1998). Utilization-focused integrative reviews in a nursing service. Applied Nursing Research, 11(4), 195–206.
   PubMed Web of Science ®Google Scholar
• Weinberger, A.H., Reutenauer, E.L., Allen, T.M., Termine, A., Vessicchio, J.C. Sacco, K.A. (2007). Reliability of the Fagerstrom test for nicotine dependence, Minnesota nicotine withdrawal scale, and Tiffany questionnaire for smoking urges in smokers with and without schizophrenia. Drug and Alcohol Dependence, 86, 278–282.
   PubMed Web of Science ®Google Scholar
• Ziedonis, D., Kosten, T., Glazer, W., & Frances, R. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45(3), 204–206.
   PubMedGoogle Scholar